Mexico - North America Obesity Treatment Market Size & Outlook
The obesity treatment market in Mexico - North America is expected to reach a projected revenue of US$ 315.9 million by 2030. A compound annual growth rate of 20.1% is expected of Mexico - North America obesity treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$104.6
Forecast, 2030 (US$M)
$315.9
CAGR, 2025 - 2030
20.1%
Report Coverage
Mexico
Mexico - North America Obesity Treatment Market, 2018-2030 (US$M)
Global Market
Related Markets
Mexico obesity treatment market highlights
- The Mexico obesity treatment market generated a revenue of USD 104.6 million in 2024 and is expected to reach USD 315.9 million by 2030.
- The Mexico market is expected to grow at a CAGR of 20.1% from 2025 to 2030.
- In terms of segment, glp-1 receptor agonists was the largest revenue generating drug class in 2024.
- Other Drug Class is the most lucrative drug class segment registering the fastest growth during the forecast period.
Obesity treatment market data book summary
| Market revenue in 2024 | USD 104.6 million |
| Market revenue in 2030 | USD 315.9 million |
| Growth rate | 20.1% (CAGR from 2025 to 2030) |
| Largest segment | Glp-1 receptor agonists |
| Fastest growing segment | Other Drug Class |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | GLP-1 Receptor Agonists, Lipase Inhibitors (Orlistat), Appetite Suppressants (Phentermine, Lorcaserin), Other Drug Class |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.7% of the global obesity treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. obesity treatment market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 48,498.2 million by 2030.
No credit card required*
Publish Date: Jan 22, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Obesity Treatment Market Scope
Obesity Treatment Market segmentation & scope
Obesity Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Baxter International Inc | View profile | 60,000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | www.baxter.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Zimmer Biomet Holdings Inc | View profile | 18,000 | 345 East Main Street, Warsaw, IN, United States, 46580 | www.zimmerbiomet.com |
| Integra Lifesciences Holdings Corp | View profile | 3,946 | 1100 Campus Road, Princeton, NJ, United States, 08540 | www.integralife.com |
| Smith & Nephew PLC | View profile | 18,452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | www.smith-nephew.com |
| Cohera Medical | View profile | 1-10 | Pittsburgh, Pennsylvania, United States, North America | www.coheramedical.com |
| HyperBranch Medical Technology | View profile | 11-50 | Durham, North Carolina, United States, North America | hyperbranch.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| CryoLife, Inc. | View profile | - | - | - |
Mexico - North America Obesity Treatment Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Obesity Treatment Market Outlook will help companies and investors design strategic landscapes.
Glp-1 Receptor Agonists was the largest segment with a revenue share of 58.13% in 2024.
Horizon Databook has segmented the Mexico - North America obesity treatment market based on glp-1 receptor agonists, lipase inhibitors (orlistat), appetite suppressants (phentermine, lorcaserin), other drug class covering the revenue growth of each sub-segment from 2018 to 2030.
- Mexico - North America Obesity Treatment Market Drug Class Outlook (Revenue, USD Million , 2018-2030)
- GLP-1 Receptor Agonists
- Lipase Inhibitors (Orlistat)
- Appetite Suppressants (Phentermine, Lorcaserin)
- Other Drug Class
- Mexico - North America Obesity Treatment Market Route of Administration Outlook (Revenue, USD Million , 2018-2030)
- Parenteral
- Oral
- Mexico - North America Obesity Treatment Market Distribution Channel Outlook (Revenue, USD Million , 2018-2030)
- Retail Pharmacies
- Hospital Pharmacies
- Other Distribution Channel
Reasons to subscribe to Obesity Treatment Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Obesity Treatment Market Outlook databook
- Our clientele includes a mix of Obesity Treatment Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico - North America Obesity Treatment Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Mexico - North America Obesity Treatment Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Mexico - North America Obesity Treatment Market, 2018-2030 (US$M)
Mexico Drug Class - Obesity Treatment Market Statistics, 2024 - 2030 (US$M)
